E-LIB Suche - Ergebnisse für: Bruin, Gerard

1

Interleukin-17A blockade with secukinumab results in decrea..:

Loesche, Christian ; Kolbinger, Frank ; Valentin, Marie-Anne...
Advances in Precision Medicine. 1 (2023) 2 - p. , 2023

Link: https://doi.org/10.18063..

2

Secukinumab for the treatment of psoriasis, psoriatic arthr..:

Kolbinger, Frank ; Di Padova, Franco ; Deodhar, Atul...
Pharmacology & Therapeutics. 229 (2022) - p. 107925 , 2022

Link: https://doi.org/10.1016/..

3

Secukinumab dosing every 2 weeks demonstrated superior effi..:

Augustin, Matthias ; Reich, Kristian ; Yamauchi, Paul...
British Journal of Dermatology. 186 (2022) 6 - p. 942-954 , 2022

Link: https://doi.org/10.1111/..

4

25482 Secukinumab efficacy and safety profile in pediatric ..:

Bodemer, Christine ; Kaszuba, Andrzej ; Kingo, Külli...
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB59 , 2021

Link: https://doi.org/10.1016/..

5

27519 Efficacy, pharmacokinetics, and tolerability of subcu..:

Sigurgeirsson, Bardur ; Schäkel, Knut ; Hong, Chih-Ho...
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB150 , 2021

Link: https://doi.org/10.1016/..

6

27599 Secukinumab administration by a 2 mL autoinjector dem..:

Sigurgeirsson, Bardur ; Browning, John ; Tyring, Stephen...
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB154 , 2021

Link: https://doi.org/10.1016/..

7

In reply: Use of a second ventilatory circuit when using a ..:

Bruin, Gerard
Canadian Journal of Anesthesia/Journal canadien d'anesthésie. 67 (2020) 8 - p. 1116-1116 , 2020

Link: https://doi.org/10.1007/..

8

Comparison of pharmacokinetics, safety and tolerability of ..:

Bruin, Gerard ; Hockey, Hans‐Ulrich P. ; La Stella, Phillip...
British Journal of Clinical Pharmacology. 86 (2020) 2 - p. 338-351 , 2020

Link: https://doi.org/10.1111/..

9

Chapter 34: A Case Study of Bridging from a Lyophilizate Fo..:

, In: Development of Biopharmaceutical Drug-Device Products; AAPS Advances in the Pharmaceutical Sciences Series,

Bruin, Gerard J. ; Picci, Marie ; Kulmatycki, Kennneth - p. 813-829 , 2020

Link: https://doi.org/10.1007/..

10

Advantages of a second ventilation circuit when using a dou..:

Bruin, Gerard
Canadian Journal of Anesthesia/Journal canadien d'anesthésie. 67 (2019) 6 - p. 766-767 , 2019

Link: https://doi.org/10.1007/..

11

263 Secukinumab, a fully human anti-interleukin-17A monoclo..:

McInnes, Iain B ; Deodhar, Atul ; Gladman, Dafna D...
Rheumatology. 58 (2019) Supplement_3 - p. , 2019

Link: https://doi.org/10.1093/..

12

Secukinumab Treatment Does Not Alter the Pharmacokinetics o..:

Bruin, Gerard ; Hasselberg, Anke ; Koroleva, Irina...
Clinical Pharmacology & Therapeutics. 106 (2019) 6 - p. 1380-1388 , 2019

Link: https://doi.org/10.1002/..

13

β-Defensin 2 is a responsive biomarker of IL-17A–driven ski..:

Kolbinger, Frank ; Loesche, Christian ; Valentin, Marie-Anne...
Journal of Allergy and Clinical Immunology. 139 (2017) 3 - p. 923-932.e8 , 2017

Link: https://doi.org/10.1016/..

14

Population Pharmacokinetic Modeling of Secukinumab in Patie..:

Bruin, Gerard ; Loesche, Christian ; Nyirady, Judit.
The Journal of Clinical Pharmacology. 57 (2017) 7 - p. 876-885 , 2017

Link: https://doi.org/10.1002/..

15

Secukinumab, a novel anti-IL-17A antibody, exhibits low imm..:

Kolbinger, Frank ; Blauvelt, Andrew ; Armstrong, April...
Journal of Dermatological Science. 84 (2016) 1 - p. e122-e123 , 2016

Link: https://doi.org/10.1016/..